Join the Allergic Rhinitis group to help and get support from people like you.
Allergic Rhinitis News (Page 2)
FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use
DUBLIN, March 17, 2022 /PRNewswire/ – Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the...
FDA Approves Ryaltris (mometasone and olopatadine) Nasal Spray for Seasonal Allergic Rhinitis
Mumbai (Maharashtra) [India], January 14, 2022 (ANI/PRNewswire) – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned...
FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use
WHIPPANY, N.J.--(BUSINESS WIRE) June 17, 2021-- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC)...
U.S. FDA Approves ALK's Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ – ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of...
FDA Medwatch Alert: Fluticasone Propionate Nasal Spray by Apotex Corp: Recall - Due to Potential for Small Glass Particles
ISSUE: The Fluticasone Propionate Nasal Spray 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the...
FDA Approves Odactra for House Dust Mite Allergies
March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...
Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use
BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...
FDA Approves Flonase Sensimist Allergy Relief
WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...
Teva Announces FDA Approval of QNASL for Children with Seasonal and Perennial Allergic Rhinitis
JERUSALEM--(BUSINESS WIRE)--Dec. 19, 2014-- Teva Pharmaceutical Industries Ltd., announced today that the U.S. Food and Drug Administration (FDA) approved QNASL (beclomethasone dipropionate) 40 mcg...
FDA Approves Flonase Allergy Relief for Sale Over-the-Counter in the United States
London UK & Parsippany, US - Thursday 24 July 2014, GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief...
FDA Approves Sanofi's Nasacort Allergy 24HR for Over-the-Counter Use
Paris, France, October 11, 2013 — Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for s...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
MEDA Announces Dymista Approved by the FDA
Göteborg, Sweden--(BUSINESS WIRE)--May 2, 2012 – The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR). In ...
Teva Announces FDA Approval of QNASL (beclomethasone dipropionate), a New Nonaqueous Nasal Aerosol, for the Treatment of Allergic Rhinitis
JERUSALEM--(BUSINESS WIRE)--Mar 26, 2012 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved QNASL Nasal Aerosol, a new, “dry” nasal aer...
FDA Approves Zetonna (ciclesonide) Nasal Aerosol for Allergic Rhinitis
FRIDAY, January 20, 2012 - The U.S. Food and Drug Administration today approved Zetonna (ciclesonide) nasal aerosol to treat the symptoms associated with seasonal and perennial allergic rhinitis in...
Further information
Related condition support groups
Related drug support groups
prednisone, Benadryl, methylprednisolone, triamcinolone, Zyrtec, Singulair, Claritin, diphenhydramine, Allegra, view more... loratadine, promethazine, Medrol, cetirizine, Phenergan, dexamethasone, Claritin-D, fexofenadine, montelukast, cyproheptadine